Lymphoblastic lymphoma
MONDO:0000873A lymphoma composed of immature small to medium-sized precursor lymphoid cells (lymphoblasts). It includes the B- and T-cell lymphoblastic lymphoma.
Also known as: lymphoblastic lymphoma, lymphoma, lymphoblastic, malignant, precursor cell lymphoblastic lymphoma, precursor lymphoblastic lymphoma, lymphoma, lymphoblastic
2016 clinical trials for this condition and its sub-types, 78 tagged with Lymphoblastic lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lymphoblastic lymphoma
-
T-lymphoblastic lymphoma 32 trials
-
Can engineered immune cells outsmart resistant blood cancers?
Cure Not yet recruitingThis early-stage trial is investigating whether a new type of CAR T-cell therapy, which targets a protein called BAFFR on cancer cells, can safely and effectively treat adults with B-cell acute lymphoblastic leukemia or B-cell lymphoblastic lymphoma that has returned or not respo…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Cure
Last updated Aug 13, 2026 00:00 UTC
-
Could early antibiotic stop be safe for kids with cancer?
Disease control Not yet recruitingThis trial looks at whether children with cancer who develop a fever and low white blood cells can safely stop antibiotics earlier than usual. About 136 children will be randomly assigned to either stop antibiotics within 24 hours or continue standard treatment. The goal is to se…
Phase 4 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Promising drug cocktail targets tough childhood cancers
Disease control Not yet recruitingThis trial tests a combination of three drugs—capivasertib, venetoclax, and dexamethasone—in children and young adults with relapsed or refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL). The study has two phases: first, to find the safest dose, and sec…
Phase 1/2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
Engineered immune cells take on tough blood cancers
Disease control Not yet recruitingThis early-stage trial tests a personalized cell therapy called CD19/22 CAR-T cells in 17 adults with relapsed or refractory acute lymphoblastic leukemia or B-cell lymphoma. Patients receive their own immune cells that have been reprogrammed to target and kill cancer cells. The s…
Phase 1/2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control
Last updated Jun 26, 2026 14:45 UTC
-
Tweaking donor cells may shield older transplant patients from a dangerous complication
Prevention Not yet recruitingResearchers are testing whether removing a specific type of immune cell, called CD45RA-positive naive T cells, from donor stem cells can prevent graft-versus-host disease in older adults undergoing stem cell transplants for acute leukemia or myelodysplastic syndrome. The trial en…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
New study tracks hidden dangers of common leukemia drug
Knowledge-focused Not yet recruitingThis study will follow 200 children with acute lymphoblastic leukemia or lymphoma to learn more about the short- and long-term side effects of asparaginase drugs. Researchers will track how often serious toxicities occur during standard treatment and a newer therapy called SJALL2…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Leukemia drug timing under the microscope: new study aims to improve dosing
Knowledge-focused Not yet recruitingThis study looks at how long the drug calaspargase pegol stays at effective levels in the blood of children and young adults with acute lymphoblastic leukemia or lymphoma. Researchers will measure drug activity and check for links to side effects. The goal is to better understand…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC